| Literature DB >> 26550026 |
Andreas Hecker1, E Schneck2, R Röhrig2, F Roller3, B Hecker2, J Holler1, C Koch2, M Hecker4, M Reichert1, C Lichtenstern2, G A Krombach3, W Padberg1, M A Weigand2.
Abstract
PURPOSES: An abdominal inflammatory focus is the second most often source of sepsis with a high risk of death in surgical intensive care units. By establishing evidence-based bundled strategies the surviving sepsis campaign provided an optimized rapid and continuous treatment of these emergency patients. Hereby the hospital mortality decreased from 35 to 30 %. Sepsis treatment is based on three major therapeutic elements: surgical treatment (source control), antiinfective treatment, and supportive care. The international guidelines of the surviving sepsis campaign were updated recently and recommend rapid diagnosis of the infection and source control within the first 12 h after the diagnosis (grade 1c). Interestingly this recommendation is mainly based on studies on soft tissue infections.Entities:
Keywords: Free intestinal perforation; Sepsis; Time-to-intervention
Year: 2015 PMID: 26550026 PMCID: PMC4636838 DOI: 10.1186/s13017-015-0047-0
Source DB: PubMed Journal: World J Emerg Surg ISSN: 1749-7922 Impact factor: 5.469
Fig. 1Study protocoll of this retrospective analysis of patients with an intestinal perforation at our university hospital: Of 179 patients with the diagnosis of a perforation in the GI-tract 79 met the inclusion criteria of this pilot study. These patients were attributed to the three study arms according to their time-to-intervention
Fig. 2The different reasons for the perforation reflects the typical pattern of a European university hospital
Fig. 3All study groups were equal concerning the duration of surgical source control. The time-to-intervention had no significant impact on the time of mechanical ventilation or the amount of catecholamins adiministered after surgery. o and * represent single spike values
Characteristics of the three study groups
| <3 h | 3–9 h | >9 h | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| Mean | SD | Median [IQR] |
| Mean | SD | Median [IQR] |
| Mean | SD | Median [IQR] |
| |
| Age | 76 | 25 | 59,64 | 18,775 | 63 [50, 74] | 36 | 64,36 | 14,934 | 65 [56.25;76.5] | 15 | 68,8 | 14,586 | 69 [61;80] | 0,205 |
| Length of hospital stay | 76 | 25 | 20,64 | 14,731 | 22 [10, 28] | 36 | 28,75 | 32,056 | 17,5 [11;29] | 15 | 20,27 | 14,235 | 16 [11;27] | 0,921 |
| Duration of surgery (minutes) | 76 | 25 | 135,2 | 73,005 | 112 [97, 165.5] | 36 | 126,58 | 68,393 | 112,5 [70;170.25] | 15 | 127,07 | 47,596 | 135 [70; 160] | 0,744 |
| Ventilatory time (hours) | 76 | 25 | 29,524 | 51,3765 | 6,2 [0.5, 19.2] | 36 | 228,253 | 9,9 [5.175; 148.75] | 15 | 105,94 | 186,3957 | 7,7 [3.9;276] | 0,141 | |
| Katecholamins (within 24 h) | 76 | 25 | 7102,32 | 15541,449 | 450 [0, 9330] | 36 | 31294,5 | 80932,459 | 1911 [0; 9700] | 15 | 4570,8 | 8733,606 | 0 [0; 2340] | 0,604 |
| Bikarbonate | 76 | 25 | 84 | 123,929 | 0 [0, 155] | 36 | 65,56 | 91,634 | 50 [0; 100] | 15 | 40 | 54,116 | 0 [0;100] | 0,656 |
| Kristalloids | 76 | 25 | 2876 | 1416,945 | 2600 [1600, 4125] | 36 | 2564,17 | 1364,581 | 2525 [1562.5; 31^37.5] | 15 | 1990 | 978,373 | 1800 [1500; 2100] | 0,184 |
| Kolloids | 76 | 25 | 854 | 1951,384 | 500 [0, 1000] | 36 | 326,39 | 421,813 | 0 [0; 500] | 15 | 400 | 430,946 | 500 [0; 500] | 0,13 |
| Substitution of erythrocyte concentrates | 76 | 25 | 276 | 465,725 | 0 [0, 1020] | 36 | 283,33 | 411,617 | 0 [0; 990] | 15 | 260 | 0 | 437,199 [0; 1200] | 0,839 |
| Thrombocyte concentrates | 76 | 25 | 20 | 70,711 | 0 | 36 | 20,83 | 71,088 | 0 | 15 | 33,33 | 129,099 | 0 | 1 |
| Fresh frozen plasma | 76 | 25 | 100 | 322,749 | 0 | 36 | 187,5 | 432,497 | 0 | 15 | 133,33 | 296,808 | 0 | 0,322 |
| Glucose substitution within24h | 76 | 25 | 15,2 | 76 | 0 | 36 | 15,2 | 76 | 0 | 15 | 40 | 129,835 | 0 | 0,987 |
| Bicarbonate substitution within 24 h | 76 | 25 | 70 | 119,024 | 0 [0, 100] | 36 | 48,53 | 101,865 | 0 | 15 | 53,33 | 104,312 | 0 [0; 50] | 0,335 |
| Kistralloid substitution within 24 h | 76 | 25 | 2990,8 | 2348,709 | 2800 [1720, 3700] | 36 | 3198,61 | 1712,078 | 2800 [2000; 4500] | 15 | 2536,67 | 1155,649 | 2250 [1700; 3000] | 0,79 |
| Kolloid substitution within 24 h | 76 | 25 | 380 | 505,8 | 0 [0, 500] | 36 | 328,57 | 404,076 | 0 [0; 500] | 15 | 833,33 | 1531,417 | 0 [0; 1000] | 0,869 |
| Erythrocyte concentrates within 24 h | 76 | 25 | 108 | 285,657 | 0 | 36 | 233,33 | 424,937 | 0 [0; 300] | 15 | 260 | 337,639 | 0 [0; 600] | 0,056 |
| Thrombocyte concentrates within 24 h | 76 | 25 | 12 | 60 | 0 | 36 | 12 | 60 | 0 | 15 | 8,33 | 50 | 0 | 0,604 |
| FFP within 24 h | 76 | 25 | 48 | 132,665 | 0 | 36 | 177,78 | 390,685 | 0 [0; 350] | 15 | 26,67 | 103,28 | 0 | 0,283 |
| SAPS_II score after source control | 76 | 25 | 42,36 | 15,508 | 43 [29.5, 50.5] | 36 | 44,28 | 15,161 | 46 [31.25; 55.75] | 15 | 41,53 | 13,674 | 38 [34; 46] | 0,894 |
| APACHE II score after soruce control | 76 | 25 | 21,08 | 8,026 | 21 [14, 26] | 36 | 21,86 | 6,69 | 21,5 [17.25; 26.5] | 15 | 19,87 | 5,718 | 20 [16; 25] | 0,79 |
| SOFA score after source control | 76 | 25 | 6,32 | 4,059 | 6 [3, 9.5] | 36 | 7,28 | 3,377 | 7 [5; 10] | 15 | 6,27 | 3,127 | 6 [4; 9] | 0,479 |
| Gastric reflux within 24 h (ml) | 76 | 25 | 166 | 225,074 | 30 [0, 300] | 36 | 266,94 | 436,347 | 100 [0; 400] | 15 | 163,33 | 227,272 | 80 [0; 250] | 0,57 |
FFP fresh frozen plasma, SAPS Simplified Acute Physiology Score, APACHE Acute Physiology and Chronic Health Evaluation II-score, SOFA Sequential Organ Failure Assessment score
Descriptive analysis of different parameters of the three study groups
| <3 h | 3–9 h | >9 h | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| Mean | SD | Median [IQR] |
| Mean | SD | Median [IQR] |
| Mean | SD | Median [IQR] |
| |
| Before surgery | ||||||||||||||
| Serum lactate | 46 | 9 | 2,45 | 1,66193 | 1,9 [1.2, 3.2] | 28 | 2,6404 | 2,67295 | 1,8 [1.175; 2.875] | 9 | 1,9733 | 0,99991 | 1,7 [1.235; 2.645] | 0,661 |
| pH | 49 | 17 | 7,34 | 0,05374 | 7,33 [7.3, 7.375] | 23 | 7,3422 | 0,10904 | 7,38 [7.24; 7.41] | 9 | 7,4144 | 0,04613 | 7,43 [7.4; 7.445] | 0,074 |
| BE | 49 | 17 | −3,3824 | 2,56131 | −3,8 [−5.35, −0.9] | 23 | −4,8 | 6,70271 | −3,8 [−8.5; 0.4] | 9 | −1,0778 | 6,41693 | −2,2 [−5.4; 1.4] | 0,95 |
| Glucose | 55 | 11 | 152,684 | 70,4683 | 138 [101, 166] | 33 | 150,494 | 73,9948 | 136 [100; 165] | 11 | 163,909 | 68,9775 | 148 [107; 176] | 0,869 |
| Hemoglobin | 75 | 24 | 12,417 | 3,0039 | 12,6 [9.7, 14.65] | 36 | 13,681 | 13,8924 | 11 [9.475; 13.575] | 15 | 10,593 | 1,9036 | 9,9 [9.1; 11.8] | 0,11 |
| Creatinine | 76 | 25 | 1,352 | 1,138 | 1 [0.8, 1.25] | 36 | 7,136 | 34,2748 | 1 [0.8; 2.05] | 15 | 1,347 | 0,9782 | 1 [0.8; 1.5] | 0,781 |
| Urea | 76 | 25 | 59,68 | 54,4225 | 41 [25, 83] | 36 | 64,764 | 62,7524 | 42,5 [32.25; 73.75] | 15 | 76,133 | 41,8857 | 63 [43; 108] | 0,175 |
| Leukocytes | 76 | 25 | 12,276 | 7,2799 | 12,3 [7.25, 17.2] | 36 | 12,328 | 8,8553 | 9,25 [7.975; 15.775] | 15 | 11,373 | 7,0199 | 9,3 [6.1; 12.9] | 0,808 |
| CRP | 75 | 25 | 141,6148 | 157,91994 | 74,3 [9.05, 253] | 36 | 168,0072 | 131,14877 | 149,175 [42.32; 250.28] | 14 | 181,7514 | 137,22675 | 155,7 [56.28; 320.4] | 0,176 |
| PCT | 12 | 3 | 13,267 | 14,584 | 10,6 [0.2, 0 | 7 | 8,714 | 12,3999 | 0,8 [0.4; 15] | 2 | 12,95 | 15,3442 | 12,95 [2.1; 0] | 1 |
| After Surgery | ||||||||||||||
| Serum lactate | 66 | 15 | 2,9718 | 2,19183 | 2,25 [1.35, 4] | 36 | 1,9333 | 1,41219 | 1,4 [1.1; 2.775] | 15 | 2,3867 | 1,92423 | 1,8 [1.2; 2.2] | 0,06 |
| pH | 74 | 23 | 7,302 | 0,082848 | 7,308 [7.231, 7.37] | 36 | 7,346 | 0,079749 | 7,35 [7.31; 7.4] | 15 | 7,33233 | 0,080053 | 7,31 [7.265; 7.4] | 0,072 |
| BE | 74 | 23 | −5,4348 | 3,49488 | −5,1 [−8.4, −3] | 36 | −3,7389 | 3,98929 | −3,8 [−5.4; −2.2] | 15 | −3,8467 | 5,18871 | −4,5 [−6.2; −2.3] | 0,059 |
| Glucose | 75 | 24 | 126,288 | 42,1621 | 122 [1104, 145.75] | 36 | 130,717 | 51,9907 | 134,5 [107.25; 144.75] | 15 | 172,467 | 54,1702 | 175 [138; 221] | 0,118 |
| Hemoglobin | 75 | 24 | 16,438 | 22,6004 | 11,9 [10.25, 13.68] | 36 | 17,181 | 28,0558 | 10,65 [9.425; 13.08] | 15 | 10,367 | 2,4555 | 10,4 [9.6; 11.6] | 0,065 |
| Creatinine | 75 | 24 | 1,304 | 1,1035 | 1 [0.9, 1.12] | 36 | 1,45 | 0,7865 | 1,2 [0.825; 1.7] | 15 | 1,267 | 0,8156 | 0,9 [0.8; 1.6] | 0,319 |
| Urea | 75 | 24 | 54,67 | 47,416 | 39,5 [26.25, 49.5] | 36 | 71,08 | 56,263 | 59 [36; 78] | 15 | 74,13 | 43,083 | 67 [47; 83] | 0,025 |
| Leukocytes | 75 | 24 | 10,129 | 5,9572 | 9,4 [4.95, 13.4 | 36 | 10,597 | 6,5088 | 8,45 [6.43; 13.2] | 15 | 12,02 | 7,4694 | 12,9 [4.6; 16.9] | 0,759 |
| CRP | 75 | 24 | 137,0608 | 110,5366 | 140,93 [31.2, 229.4] | 36 | 168,595 | 107,2545 | 156,555 [76.8; 228.5] | 15 | 182,9213 | 104,25169 | 184,2 [115; 256] | 0,175 |
| PCT | 13 | 3 | 20,933 | 20,9381 | 17,7 [1.8, 0] | 9 | 20,933 | 20,9381 | 17,7 [5.35; 29.6] | 1 | 26,356 | 34,8009 | 14,4 [9.75; 30.5] | 1 |
BE base excess, CRP C-reactive protein, PCT procalcitonin
General description of the three study groups conerning OP technique, antibiotics and others
| Total | Up to 3 h. | 3 to 9 h. | More than 9 h. | |||||
|---|---|---|---|---|---|---|---|---|
| Gender | n | % | n | % | n | % | n | % |
| Female | 31 | 41 % | 8 | 32 % | 13 | 36 % | 10 | 67 % |
| Male | 45 | 59 % | 17 | 68 % | 23 | 64 % | 5 | 33 % |
| Total | 76 | 100 % | 25 | 100 % | 36 | 100 % | 15 | 100 % |
| Ventilation | N | % | n | % | n | % | n | % |
| Not ventilated | 16 | 21 % | 5 | 20 % | 8 | 22 % | 3 | 20 % |
| Ventilated | 60 | 79 % | 20 | 80 % | 28 | 78 % | 12 | 80 % |
| Total | 76 | 100 % | 25 | 100 % | 36 | 100 % | 15 | 100 % |
| OP-method | N | % | n | % | n | % | n | % |
| Laparascopic | 2 | 3 % | 2 | 8 % | 0 | 0 % | 0 | 0 % |
| Open | 74 | 97 % | 24 | 92 % | 35 | 97 % | 15 | 100 % |
| Converted | 2 | 3 % | 0 | 0 % | 1 | 3 % | 0 | 0 % |
| Total | 76 | 100 % | 26 | 100 % | 36 | 100 % | 15 | 100 % |
| Antibiotics | N | % | n | % | n | % | n | % |
| No antibiotics | 2 | 3 % | 0 | 0 % | 0 | 0 % | 2 | 13 % |
| Antibiotics | 74 | 97 % | 25 | 100 % | 36 | 100 % | 13 | 87 % |
| Total | 76 | 100 % | 25 | 100 % | 36 | 100 % | 15 | 100 % |
| Revision | N | % | n | % | n | % | n | % |
| No revision | 47 | 62 % | 14 | 56 % | 22 | 61 % | 11 | 73 % |
| Revision | 29 | 38 % | 11 | 44 % | 14 | 39 % | 4 | 27 % |
| Total | 76 | 100 % | 25 | 100 % | 36 | 100 % | 15 | 100 % |
| Ischemia | N | % | n | % | n | % | n | % |
| No ischemia | 67 | 88 % | 22 | 88 % | 31 | 86 % | 14 | 93 % |
| Ischemia | 9 | 12 % | 3 | 12 % | 5 | 14 % | 1 | 7 % |
| Total | 76 | 100 % | 25 | 100 % | 36 | 100 % | 15 | 100 % |
Fig. 4The time-courses of creatinine (a), urea (b), C-reactive protein (CRP) (c) and serum lactate (d) before surgical source control and in the postoperative phase. o and * represent single spike values